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In South Africa, access to renal replacement therapy (RRT) and 
transplantation is limited, mainly owing to resource constraints. In 
the Western Cape Province, approximately half of the public sector 
patients with stage 5 chronic kidney disease are denied RRT. [1] 
Those who are accepted are typically good transplant candidates 
with favourable outcomes when transplanted (5-year patient and 
graft survival rates of 83.5% and 77.9%, respectively). Low national 
organ donation (1.4 per million population (pmp)) and renal 
transplantation rates (4.7 pmp)[1] demand optimal utilisation of this 
precious resource.
This article is based on recent adverse events encountered during renal 
transplantation at our institution, possibly associated with the prolonged 
use of femoral haemodialysis catheters (FHCs). Cumbersome dissection 
of target vasculature, prolonged anastomosis time and unpredictable 
venous outflow were some of the difficulties experienced, resulting in 
unsalvageable early graft thrombosis on two occasions.
Despite the anecdotal nature of these findings, we believe that 
the association with FHCs was not incidental. In the absence of 
prospective data, with glaring ethical concerns prohibiting further 
investigation by a randomised control trial, we attempt to answer 
three relevant questions by applying clinical experience and the best 
evidence at hand.
1. Are venous complications 
associated with upper-extremity 
haemodialysis catheters applicable  
to FHCs?
Prolonged catheterisation of the upper-extremity venous system may 
induce structural damage and (in its most extreme form) lead to 
central vein stenosis (CVS). Owing to its crippling effect on future 
vascular access, CVS has been extensively studied. In our opinion, in 
the absence of literature evaluating aetiopathological factors specific 
to lower-extremity venous stenosis, valuable parallels may be drawn 
from the substantial pool of data on CVS. However, one should 
recognise unique anatomical differences and how these may affect 
the development of venous complications.
The development of haemodialysis catheter-associated CVS is 
based on an interplay of mechanical forces, generated by dynamic 
mediastinal structures and turbulent flow.[2] Vein-wall thickening, 
proliferation of smooth-muscle cells and focal catheter attachment 
to the vein wall are consequences of prolonged catheter use.[3] A 
comparable interplay of mechanical forces applies to FHCs. Although 
dynamic mediastinal structures do not contribute to mechanical 
forces in the lower-limb setting, the mechanical implications of a 
relatively rigid intraluminal device positioned in an anatomically 
dynamic region have to be considered.
Areas of natural anatomical narrowing have been described and 
render the vessel wall vulnerable to direct mechanical trauma. In 
the upper extremities, these areas include the subclavian vein at the 
costoclavicular junction and the left brachiocephalic vein as it crosses 
a relatively fixed, pulsatile fulcrum of brachiocephalic artery and 
aorta.[4,5] Comparable areas in the lower-extremity venous system 
include both (but especially the left) common iliac veins where they 
are crossed by the right common iliac artery (Fig. 1).
Reports specifically evaluating the impact of FHCs on the surround-
ing vasculature are limited.[6,7] A retrospective study, including 
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Fig. 1. Potential areas of natural anatomical narrowing in the iliac veins. 
(R = right; L = left; 1 = proximal (L) common iliac vein compressed by 
(R)  common iliac artery; 2 = proximal (R) common iliac vein compressed 
by (R) common iliac artery; 3 = distal (L) common iliac vein compressed 
by (L) internal iliac artery; 4 = distal (R) common iliac vein compressed by 
(R) internal iliac artery.)
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24 patients receiving haemodialysis by way of a temporary FHC, 
investigated the frequency of post-catheterisation common femoral/
external iliac vein stenosis.[6] Magnetic resonance (MR) venography 
(comparable to conventional venography)[8] confirmed venous 
stenoses in 4 of the 14 patients (29%) with >14 catheter days. All 
stenoses observed were in the subgroup of patients with >30 catheter 
days. Comparatively, the reported stenosis rates with internal jugular 
and subclavian vein catheters are 10%[9] and 20 - 50%,[9-11] respectively.
In another study, 7 of 27 patients (26%) with tunnelled FHCs 
presented with ipsilateral lower-extremity swelling within 10 days 
of insertion. Deep-vein thromboses were ultrasonographically 
confirmed in all 7 cases.[12]
2. What are the implications of 
prolonged FHC use, with specific 
reference to renal transplantation?
Several imaging modalities (including duplex ultrasound,[13,14] 
computed tomography venography and (3-D) MR venography[15]) 
have been validated in the diagnosis and exclusion of post-
catheterisation venous stenosis. However, exclusion of significant 
stenosis (accepted as ≥50%) does not necessarily predict successful 
transplantation. Once reperfused, the renal allograft will receive 
approximately 10 - 12% of the recipient’s cardiac output. This equates 
to an increase in iliac vein outflow of approximately 550 mL/min 
in a 70 kg adult male.[16] In the presence of unrecognised upstream 
perivascular fibrosis and reduced venous compliance, a functional 
stenosis may only be unmasked upon reperfusion, potentially leading 
to allograft congestion and early renal vein thrombosis. 
Successful transplantation contralateral to the side of suspected 
venous pathology has been described.[6] However, an important 
consideration is the physical length of the catheter and its position 
relative to the common iliac vein confluence (Fig. 2). Long-term 
(tunnelled) FHCs are often longer than their temporary (non-
tunnelled) counterparts, therefore potentially compromising contra-
lateral external iliac vein outflow should stenosis develop.
In patients with venous pathology precluding heterotopic renal 
transplantation, an orthotopic site may be considered. In the largest 
orthotopic renal transplant series to date (223 transplants over a 
31-year period) excellent 1-, 10- and 20-year overall patient (92%, 
78% and 63%) and graft (88%, 59% and 35%) survival were reported, 
with no difference in 20-year patient or graft survival compared with 
heterotopic transplants.[17] However, the procedure is technically 
demanding and associated with high surgical complication rates 
(66.7%) when performed infrequently.[18]
3. How should one approach the 
chronic haemodialysis patient in  
need of an FHC?
Preserving the likelihood of successful transplantation is key. 
FHCs should be reserved for cases where internal jugular vein 
catheterisation is unsuccessful or contraindicated, with catheter 
days restricted to a minimum. Early referral to an access surgeon 
allows sufficient time for preoperative planning and usually results 
in prompt creation of alternative access in the majority of patients.
Patients with bilateral CVS not amenable to endovenous 
intervention present a unique challenge. The optimal long-term 
solution is expedited renal transplantation, and this should be 
motivated for by the treating physician on the basis of precarious 
vascular access. Reassessment for peritoneal dialysis is often 
overlooked, and relative contraindications should not apply in the 
face of dwindling vascular access. Owing to generally uninspiring 
outcomes, lower-extremity arteriovenous (AV) fistulas/grafts should 
not be viewed as sustainable access, but rather as a ‘bridge’ to 
transplantation.[19] In our opinion, all the above options should be 
explored prior to insertion of a long-term FHC as definitive access.
Conclusion
The correlation between early graft thrombosis and prolonged 
FHC use cannot be scientifically proven at this time. However, 
retrospective reports suggest that the iliac veins are not exempt 
from the venous complications associated with upper-extremity 
haemodialysis catheters. Although successful transplantation is 
still likely, prolonged FHC use may result in avoidable surgical 
complexities that cannot be reliably predicted preoperatively. Early 
graft thrombosis, despite occurring rarely, is not only devastating 
to the recipient and surgeon involved, but may also impact on the 
patient awaiting a chronic dialysis slot.
We therefore strongly believe that FHC placement should be 
reserved for patients in whom internal jugular vein catheterisation 
was unsuccessful or is contraindicated. A proactive approach to 
establishing alternative dialysis access is required in an effort to 
limit femoral catheter days, especially in patients who are still 
considered for transplantation. Where upper-limb access options are 
not viable, expedited renal transplantation, peritoneal dialysis and 
lower-extremity AV fistulas/graft creation should all be considered 
prior to insertion of a long-term FHC as definitive access.
Transplant surgeons should be informed of all patients on the 
waiting list with current or previous catheters beyond the common 
iliac vein confluence (or within both external iliac veins) for more than 
30 cumulative days, as difficult transplantation should be anticipated. 
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